Snapshot from Jul 20, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Draupnir Holding
Entity

Draupnir Holding

Tracked across 1 events · 7 articles · First seen Jul 19, 2026 · Last active Jul 20, 2026

Sentiment
30
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 30
Business
Samsung Biologics acquires PolyPeptide Group
Samsung Biologics — Samsung Biologics America, a South Korean contract drug manufacturer, announced on July 20, 2026, an all-cash public tender offer to acquire Swiss peptide drug manufacturer PolyPeptide Group for approximately 1.46 billion Swiss…
Impact: Major shareholder (55.65%) agreed to tender its stake, supporting the deal.
Jul 19, 2026 · 7 articles
Key Actions (1)
90 Draupnir Holding agreed to tenderSamsung Biologics acquires...
ERGEN INTELLIGENCE
Track Draupnir Holding live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.